205 results
Page 8 of 11
8-K
EX-3.1
tbahd86l
8 May 19
Amendments to Articles of Incorporation or Bylaws
4:34pm
8-K
EX-99.1
3mn0exfd5rsj
6 May 19
ContraVir Pharmaceuticals Receives Positive Nasdaq Listing Decision
12:55pm
424B4
bey6epnmj8elzl0rszi
26 Apr 19
Prospectus supplement with pricing info
3:56pm
8-K
EX-10.1
jw0o6fgi lzqj
19 Mar 19
Entry into a Material Definitive Agreement
4:56pm
8-K
EX-99.1
euxp6ic6dfy6zitypl4
15 Jan 19
ContraVir Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders
8:38pm
8-K
EX-99.1
02euu38 1qn
3 Oct 18
Departure of Directors or Certain Officers
4:31pm
8-K
EX-99.1
uhqc9m
6 Aug 18
ContraVir Pharmaceuticals Provides an Update to Corporate Objectives
5:27pm
8-K
EX-99.1
6ea60yomtbc
23 Jul 18
ContraVir Pharmaceuticals Reports Progress in Phase 1/2A Trial of CRV431
12:37pm
8-K
EX-3.1
keroxi
5 Jul 18
Material Modifications to Rights of Security Holders
4:03pm
8-K
EX-99.1
82znk0gp ipma8ihl
25 Jun 18
Other Events
11:24am
424B4
4vlrn382geb3 pe
15 Jun 18
Prospectus supplement with pricing info
12:26pm
8-K
EX-99.1
qfrgpt8efmb
6 Jun 18
ContraVir Pharmaceuticals Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering
6:01am
8-K
EX-99.1
s5jj pmixyyw4trpg
31 May 18
Other Events
8:21am